Volume 94 Issue 29 | p. 13 | News of The Week
Issue Date: July 18, 2016 | Web Date: July 13, 2016

Money flows for drug service firms

Converging investments highlight strength in the Western service sector
Department: Business
Keywords: pharmaceutical chemicals, initial public offering, contract manufacturing, pharmaceutical services, acquisition

Three events converged in the pharmaceutical services sector last week to serve as a reminder that Western drug manufacturing and research service firms are on a roll.

Patheon’s launch of an initial public offering (IPO) of stock; Cambrex’s completion of an expansion at its Charles City, Iowa, site; and Albany Molecular Research Inc.’s acquisition of Euticals all indicate that the sector is strong and growing in the U.S. and Europe.

. . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society